BioSpace News Archive

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces that the United State Patent and Trademark Office (USPTO) has recently published two key patent applications filed by the Company.

SOPHiA GENETICS SA today announced it will release its financial results for the fourth quarter and full year 2021 before U.S. markets open on Tuesday, March 15, 2022.

Medunik USA is pleased to announce that Siklos® (hydroxyurea), previously indicated to reduce the frequency of painful crises and to reduce the need for blood transfusions in pediatric patients, 2 years of age and older, with sickle cell anemia with recurrent moderate to severe painful crises4, has now been approved for use in adults for the same indication.

PharmaBlock announces the appointment of Dr. Zhengtian (Titan) Gu as Senior Vice President of Quality and Regulatory Affairs, responsible for corporate quality management and regulatory affairs.

Enanta Pharmaceuticals, Inc. today announced that it has dosed the first subject in its Phase 1 clinical trial of EDP-235, a coronavirus 3CL protease inhibitor (also known as the main coronavirus protease, or Mpro) specifically designed as a once-daily, oral treatment for COVID-19.

Sage Therapeutics, Inc. (Nasdaq: SAGE), and Biogen Inc. (Nasdaq: BIIB) today announced the CORAL Study in people with major depressive disorder (MDD) met the trial objectives.

Star Therapeutics has formed a family of companies, and Electra Therapeutics is the first to be spun out with a lead monoclonal antibody in Phase 1 clinical development.

LEXEO Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for LX2006.

Alivia Analytics, the industry leader providing solutions that are revolutionizing healthcare payment integrity, today announced the addition of Michael Boutte to their executive leadership team.

Cytokinetics, Incorporated (Nasdaq: CYTK) and the American Heart Association (AHA) Bay Area today announced a three-year collaboration to accelerate education and awareness of heart disease.